GBIO Latest Quarter's Earnings
Announce Date 11/05/2025
EPS Normalized Actual $-0.82 (Beat by $2.36)
EPS GAAP Actual $-0.82 (Beat by $2.36)
Revenue Actual $0.001594B
Revenue Surprise Beat by $1.594M
Upcoming Quarter's Earnings
Announce Date 03/30/2026 (Pre-Market)
EPS Normalized Estimate $-0.2442
EPS GAAP Estimate $-0.2442
Revenue Estimate $0.0001114B
Annual EPS Estimate
Fiscal Period Ending EPS Estimate Forward PE Low High # of Analysts
Dec 2029 -0.14 -38.14 -0.37228 0.02670588 1
Dec 2028 -1.215 -4.4 -1.215 -1.215 2
Quarterly EPS History
Period EPS Beat / Miss Revenue YoY Beat / Miss
FQ3 2025 (Sep 2025) -0.82 -0.47 0.001594B -373.9% 0.94M
FQ2 2025 (Jun 2025) -3.12 -2.9098 0.000765B -434.77% 0.12M
FQ1 2025 (Mar 2025) -0.22 0.1434 0.008723B 53.47% 8.07M
FQ4 2024 (Dec 2024) -0.23 0.04571 0.004188B 31.28% 2.44M
FQ3 2024 (Sep 2024) -0.23 -1.77141 0.007554B 71.59% 5.57M
FQ2 2024 (Jun 2024) -0.31 -0.31 0.004091B 78.49% 4.09M
FQ1 2024 (Mar 2024) -1.12 -1.12 0.004059B 100% 4.06M
FQ4 2023 (Dec 2023) -0.0006 -0.0006 0.002878B 100% 2.88M
Quarterly Estimates Summary

FQ4 Announce Date

03/30/2026 (Pre-Market)

Consensus EPS Estimates

-0.2442

Consensus Revenue Estimates

0.0001114B

Consensus EPS Estimates
Fiscal Period Ending EPS Estimate YoY Growth(%) Low High # of Analysts
FQ4 2026 (Oct 2026) -0.0991 -- -0.10806 -0.08971503 1
FQ3 2026 (Jul 2026) -0.0985 -732.49 -0.1074 -0.08917185 1
FQ2 2026 (Jun 2026) -0.2445 -1176.07 -0.31785 -0.11369 3
FQ1 2026 (Mar 2026) -0.2442 9.91 -0.31746 -0.11355 3
Consensus Revenue Estimates
Fiscal Period Ending Revenue Estimate YoY Growth(%) Low High # of Analysts
FQ4 2026 (Oct 2026) 0B -- 0B 0B 1
FQ3 2026 (Jul 2026) 0B 60.73 0B 0B 1
FQ2 2026 (Jun 2026) 0B -586.71 0B 0B 1
FQ1 2026 (Mar 2026) 0B -7730.34 0B 0B 1
Quarterly Estimates Revisions

EPS # of Up Revisions

4

EPS # of Down Revisions

4

Revenue # of Up Revisions

6

Revenue # of Down Revisions

3

Consensus EPS Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Consensus Revenue Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Earnings Surprise Summary

EPS # of Beats

2

EPS # of Misses

6

EPS # of in-lines

0

Revenue # of Beats

8

Revenue # of Misses

0

Revenue # of in-lines

0

Earnings Surprise (EPS) - Actual vs Consensus
Earnings Date EPS Estimate EPS Actual Surprise Surprise %
FQ3 2025 (Sep 2025) -0.35 -0.82 -0.47 57.32%
FQ2 2025 (Jun 2025) -0.2102 -3.12 -2.9098 93.26%
FQ1 2025 (Mar 2025) -0.3634 -0.22 0.1434 -65.18%
FQ4 2024 (Dec 2024) -0.27571 -0.23 0.04571 -19.87%
FQ3 2024 (Sep 2024) 1.54141 -0.23 -1.77141 770.18%
FQ2 2024 (Jun 2024) -0.31 -0.31 100%
FQ1 2024 (Mar 2024) -1.12 -1.12 100%
FQ4 2023 (Dec 2023) -0.0006 -0.0006 100%
Revenue Surprise - Actual vs Consensus
Earnings Date Revenue Estimate Revenue Actual Surprise Surprise %
FQ3 2025 (Sep 2025) $0B $0B $0.94M 59.22%
FQ2 2025 (Jun 2025) $0B $0B $0.12M 15.03%
FQ1 2025 (Mar 2025) $0B $0.01B $8.07M 92.55%
FQ4 2024 (Dec 2024) $0B $0B $2.44M 58.21%
FQ3 2024 (Sep 2024) $0B $0.01B $5.57M 73.79%
FQ2 2024 (Jun 2024) $0B $0B $4.09M 100%
FQ1 2024 (Mar 2024) $0B $0B $4.06M 100%
FQ4 2023 (Dec 2023) $0B $0B $2.88M 100%
Unlock